Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-25 @ 11:25 PM
Study NCT ID:
NCT00056693
Status:
COMPLETED
Last Update Posted:
2008-07-21
First Post:
2003-03-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Treatment With SU11248 in Patients With Neuroendocrine Tumors
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RTKC-0511-015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc